HFA
TECH icon

HC Financial Advisors’s Bio-Techne TECH Stock Holding History

HC Financial Advisors’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-120
Closed -$16K – 339
2021
Q4 		$16K Hold
120
– – 0.01% 220
2021
Q3 		$15K Hold
120
– – 0.01% 212
2021
Q2 		$14K Hold
120
– – 0.01% 216
2021
Q1 		$11K Hold
120
– – 0.01% 248
2020
Q4 		$10K Hold
120
– – 0.01% 271
2020
Q3 		$7K Hold
120
– – 0.01% 293
2020
Q2 		$8K Hold
120
– – 0.01% 259
2020
Q1 		$6K Buy
+120
New +$6K 0.01% 285

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
OCBV
Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

HC Financial Advisors's TECH Position: Q1 2022 in Review

HC Financial Advisors sold out of Bio-Techne (TECH) in Q1 2022, closing a stake of 120 shares — an estimated $16K sold.

HC Financial Advisors first reported a position in TECH in Q1 2020 and held it in 8 quarters. The position peaked at $16K in Q4 2021. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2022.

  • HC Financial Advisors reported no remaining Bio-Techne position as of Q1 2022 after selling out during the quarter.
  • HC Financial Advisors sold 120 Bio-Techne shares in Q1 2022, an estimated $16K.
  • HC Financial Advisors first reported a position in Bio-Techne in Q1 2020 and held it in 8 quarters.
  • HC Financial Advisors's Bio-Techne position peaked at $16K in Q4 2021.
  • 557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2022.

Based on HC Financial Advisors's 13F filing for Q1 2022, filed 4 May 2022.